Conference Coverage
Conference Coverage
Initiate Interferon Beta-1a Early to Delay Progression to MS
Major Finding: The 36-month cumulative probability of clinically definite MS was 41.3% for the placebo/delayed-treatment group, 27.6% for the once...
Conference Coverage
Slowed Infusions Cut Hypersensitivity Reactions in Rituximab Desensitization
Major Finding: Rituximab desensitization by standard infusion resulted in a 29% hypersensitivity-reaction rate, but rate-controlled infusion...
Conference Coverage
Surgical Removal of Brain Thrombus Boosts Recovery
Major Finding: Treating intracerebral hemorrhage with minimally invasive surgery plus intracerebral rTPA increased mRS 1-3 recoveries by 10%...
Conference Coverage
Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
Major Finding: The PFO-attributable risk for a previous cryptogenic stroke varied between 0% in some patients with a PFO to 88% in others.Data...
Conference Coverage
Tenecteplase Edges TPA in Acute Stroke
Conference Coverage
CT Perfusion in Acute Stroke Questioned
Major Finding: CT perfusion imaging of ischemic stroke patients boosted average time to reperfusion by 48 minutes, compared with noncontrast CT,...
Conference Coverage
Nearly Half of U.S. Stroke Patients Remain Hypertensive
Major Finding: Among a representative sample of 490 Americans aged 40 years or older with a history of stroke, 47% had uncontrolled hypertension....
Conference Coverage
Most Febrile Seizures Don't Lead to Epilepsy
Major Finding: Children with febrile seizures were almost 10 times more likely to develop epilepsy than were their peers, yet their standardized...
Conference Coverage
Valproate Exposure Associated With Autism, Lower IQ
Conference Coverage
Implanted EEG Device Predicts Seizures in Early Study
Major Finding: The sensitivity of the device for time periods deemed to have a high likelihood of impending seizure ranged from 0.56 to 1.00 in...
Conference Coverage
Progesterone Quells Some Intractable Catamenial Seizures
Major Finding: Cyclical natural progesterone therapy decreased seizure frequency by up to 71%, compared with placebo, in women with a high number...